These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35606332)

  • 1. Corrigendum to 'A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential' [Eur J Heart Fail 2022;24:466-480].
    Eur J Heart Fail; 2022 Sep; 24(9):1739. PubMed ID: 35606332
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to 'Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential'[Eur J Heart Fail 2015; 17:764-771].
    Eur J Heart Fail; 2015 Sep; 17(9):985. PubMed ID: 26377117
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to 'Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy' [Eur J Heart Fail 2021;23:854-871].
    Eur J Heart Fail; 2022 Apr; 24(4):732. PubMed ID: 35301785
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to 'Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy' [Eur J Heart Fail 2021;23:527-540].
    Eur J Heart Fail; 2022 Apr; 24(4):733. PubMed ID: 35274424
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to 'Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry [Eur J Heart Fail 2021;23:1844-1854].
    Eur J Heart Fail; 2022 Apr; 24(4):732. PubMed ID: 35274422
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to 'Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials' [Eur J Heart Fail 2016;18:684-692].
    Eur J Heart Fail; 2021 Nov; 23(11):1991. PubMed ID: 34605597
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to 'Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata' [Eur J Heart Fail 2022;24:1047-1062].
    Eur J Heart Fail; 2022 Oct; 24(10):1995. PubMed ID: 36126686
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to 'Iron deficiency and risk of early readmission following a hospitalization for acute heart failure' [Eur J Heart Fail 2016;18:880-880].
    Eur J Heart Fail; 2022 Mar; 24(3):591. PubMed ID: 34897918
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to 'Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction' [Eur J Heart Fail 2021; 23: 983-991].
    Eur J Heart Fail; 2021 Oct; 23(10):1802. PubMed ID: 34514683
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2020;22:181-195].
    Eur J Heart Fail; 2020 Jul; 22(7):1287. PubMed ID: 32945099
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to 'Heart failure at the crossroads: moving beyond blaming stakeholders to targeting the heart' [Eur J Heart Fail] 2015 August;17(8): 760-763. doi:10.1002/ejhf.315.
    Eur J Heart Fail; 2015 Dec; 17(12):1317. PubMed ID: 26647216
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to 'Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry' [Eur J Heart Fail 2020;22:92-102].
    Eur J Heart Fail; 2020 Jul; 22(7):1287. PubMed ID: 32945101
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to 'Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU' [Eur J Heart Fail 2019;21:322-333].
    Eur J Heart Fail; 2020 Jan; 22(1):170. PubMed ID: 32003136
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to 'Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry' [Eur J Heart Fail 2020;22:103-112].
    Eur J Heart Fail; 2020 Jul; 22(7):1287. PubMed ID: 32945100
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to 'Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology' [Eur J Heart Fail 2018;20:3-15].
    Corrà U; Agostoni PG; Anker SD; Coats AJS; Crespo Leiro MG; de Boer RA; Harjola VP; Hill L; Lainscak M; Lund LH; Metra M; Ponikowski P; Riley J; Seferović PM; Piepoli MF
    Eur J Heart Fail; 2018 Oct; 20(10):1501. PubMed ID: 30303623
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative'[Eur J Heart Fail 2016; 18:66-70].
    Eur J Heart Fail; 2016 Feb; 18(2):217. PubMed ID: 26861040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to 'Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015' [Eur J Heart Fail 2019;21:1329-1337].
    Metra M; Lucioli P
    Eur J Heart Fail; 2020 Apr; 22(4):759. PubMed ID: 32342580
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to 'Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction' [Eur J Heart Fail 2022;24:782-790].
    Eur J Heart Fail; 2022 Oct; 24(10):1996. PubMed ID: 36098209
    [No Abstract]   [Full Text] [Related]  

  • 19. A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential.
    Banerjee A; Pasea L; Chung SC; Direk K; Asselbergs FW; Grobbee DE; Kotecha D; Anker SD; Dyszynski T; Tyl B; Denaxas S; Lumbers RT; Hemingway H
    Eur J Heart Fail; 2022 Mar; 24(3):466-480. PubMed ID: 34969173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to 'Weight change and clinical outcomes in heart failure with reduced ejection fraction: Insights from EMPEROR-Reduced' [Eur J Heart Fail 2023;25:117-127].
    Eur J Heart Fail; 2023 Jun; 25(6):924. PubMed ID: 37278104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.